Janssen Pharmaceutica N.v., Belgium

This study tests an experimental vaccine (JNJ-64042056) designed to help the immune system clear a harmful brain protein called tau. It includes 55 people with very early Alzheimer's signs but no memory problems. The goal is to see if the vaccine can slow tau buildup in the brain…